NEW YORK (360Dx) – Plasma levels of the metabolite trimethylamine N-oxide can predict both near- and long-term cardiovascular events in patients with chest pain, according to a new study.

Gut microbes produce trimethylamine N-oxide (TMAO) from precursors found in red meat, eggs, and dairy products, and high levels of the metabolite have been associated with blood clots and blood vessel inflammation, suggesting that it could also be linked to major adverse cardiovascular events like heart attack, stroke, or death.

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease.